BCM
BML Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Hold |
1,136,091
| – | – | 1.67% | 13 |
|
|
2025
Q1 | $909K | Hold |
1,136,091
| – | – | 0.74% | 19 |
|
|
2024
Q4 | $2.68M | Hold |
1,136,091
| – | – | 1.67% | 14 |
|
|
2024
Q3 | $1.73M | Buy |
1,136,091
+33,196
| +3% | +$50.5K | 1.02% | 16 |
|
|
2024
Q2 | $1.46M | Buy |
1,102,895
+496,750
| +82% | +$656K | 1.04% | 15 |
|
|
2024
Q1 | $1.09M | Buy |
606,145
+163,793
| +37% | +$293K | 0.72% | 21 |
|
|
2023
Q4 | $739K | Buy |
442,352
+169,852
| +62% | +$284K | 0.56% | 23 |
|
|
2023
Q3 | $845K | Hold |
272,500
| – | – | 0.78% | 15 |
|
|
2023
Q2 | $777K | Buy |
272,500
+52,500
| +24% | +$150K | 0.7% | 22 |
|
|
2023
Q1 | $867K | Buy |
220,000
+40,000
| +22% | +$158K | 0.75% | 25 |
|
|
2022
Q4 | $713K | Buy |
+180,000
| New | +$713K | 0.68% | 19 |
|